RxDoctor Payments Data

James Bertus, MD

Pain Medicine · Norfolk, NENPI 1447357462

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.6%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Genesys Orthopedics Systems, L.L.C. at 34.2% of the total. Reporting peaked in 2024 at $1,923 and has fallen 96.0% since, to $77 in 2025. That places this record below the midpoint for pain medicine clinicians in NE, where the typical reported total is $4,468.

$4,468in general payments, 2019–2025

Across 120 payments — averaging $37.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genesys Orthopedics Systems, L.L.C.$2K
  • Spinal Simplicity, LLC$1K
  • Abbott$322
  • Boston Scientific$282
  • AbbVie$176
  • Forte Bio-pharma LLC$119
  • plus $796 from 17 others

What the payments were for

  • Travel & lodging$2,44055%
  • Food & beverage$2,01345%
  • Gifts$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,468 in reported general payments places this provider in the 50th percentile of 31 pain medicine providers in Nebraska.

See all pain medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$247,920
Medicare patients
554
Services billed
5,803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate30$19,524
Buprenorphine53$11,568
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen56$7,566
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen163$3,588
Fentanyl27$2,409
Morphine Sulfate ErMorphine Sulfate43$1,520
Tramadol Hcl193$1,204
Gabapentin76$926
Pregabalin45$845
Morphine Sulfate25$621
Duloxetine Hcl56$360
Oxycodone Hcl36$357
Tizanidine Hcl37$208
Celecoxib11$133
Methylprednisolone13$121

Paid to pharmacies, not to this prescriber.

Other pain medicine in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →